28 images for tyrosine | ||||
Tyrosine kinase-activated protein degradation [Cell Biology]Posttranslational knockdown of a specific protein is an attractive approach for examining its function within a system. Here we introduce phospho-dependent proteolysis targeting chimeras (phosphoPROTACs), a method to couple the conditional ... PNAS, 1 week ago
Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma
Elites TV, 1 week ago
Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder
Elites TV, 2 weeks ago
Association of the Protein-Tyrosine Phosphatase DEP-1 with Its Substrate FLT3 Visualized by In Situ Proximity Ligation Assay
Elites TV, 3 weeks ago
|
ADAM-10/-17 feedbacks govern cell migration [Systems Biology]A Disintegrin and Metalloproteinases (ADAMs) are the principal enzymes for shedding receptor tyrosine kinase (RTK) ectodomains and ligands from the cell surface. Multiple layers of activity regulation, feedback, and catalytic promiscuity impede our ... PNAS, 1 week ago
|
PKA enhances Rac-PAK signaling to Erk1/2 [Biochemistry]Activated G protein-coupled receptors (GPCRs) and receptor tyrosine kinases relay extracellular signals through spatial and temporal controlled kinase and GTPase entities. These enzymes are coordinated by multifunctional scaffolding proteins for ... PNAS, 2 weeks ago
|
TKI resistance markers found for NSCLC patientsmedwireNews: Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor (TKI) therapy in patients with epidermal growth factor receptor (EGFR)-activating, non-small-cell lung cancer ... MedWire News, 2 weeks ago
PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
Sys-Con Media, 3 days ago
United States chronic myeloid leukemia market: Latest market research analysed
TransWorldNews, 3 days ago
Global Bosulif market: New market research published
TransWorldNews, 3 days ago
|
Kala Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase InhibitorData Presented at ARVO 2013 Annual Meeting Demonstrated Potential of Kala's Proprietary Mucosal-Penetrating Particle Technology for Ocular Disease ARVO 2013 WALTHAM, Mass.--( Topical RTKi-MPP showed a 5-fold enhancement in retinal drug ... Drugs.com, 2 weeks ago
Kala Provides Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor
Individual.com, 2 weeks ago
Kala Pharmaceuticals Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor
BioSpace, 2 weeks ago
Langer's Kala touts positive results for topical wet AMD treatment
FiercePharma, 2 weeks ago
|
EU Regulatory Authorities Grant Orphan Status to Eisai's Lenvatinib for the Treatment of Radioiodine-Refractory..HATFIELD, England Orphan status also granted in Switzerland The investigational multi-tyrosine kinase inhibitor (TKI), lenvatinib (development code: E7080), has today been granted orphan drug designation (ODD) for the treatment of follicular and ... ADVFN UK, 2 weeks ago
More from: OSIX News, Reuters UK...and 11 other sources
|
Studies from Shanghai Jiaotong University in the Area of Receptor Protein-Tyrosine Kinases Described(NewsRx) -- By a News Reporter-Staff News Editor at Angiogenesis Weekly -- Data detailed on Enzymes and Coenzymes have been presented. According to news reporting from Shanghai, People's Republic of China, by NewsRx journalists, research stated, "To ... NewsRX, 1 day ago
New Findings Reported from National Institutes of Health Describe Advances in Receptor Protein-Tyrosine Kinases
NewsRX, 1 week ago
Study Results from University of Georgia Provide New Insights into Protein Tyrosine Phosphatases
NewsRX, 2 weeks ago
Data from Eli Lilly Advance Knowledge in Proteomics
NewsRX, 1 day ago
More from: , NewsRX...and 1 other sources
|
Profiling Epidermal Growth Factor Receptor and Heregulin Receptor 3 Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technologyby Mohammed Akli Ayoub, Heng B. See, Ruth M. Seeber, Stephen P. Armstrong, Kevin D. G. Pfleger Heteromerization can play an important role in regulating the activation and/or signal transduction of most forms of receptors, including receptor ... Elites TV, 5 days ago
ArQule to Report First Quarter 2013 Financial Results on May 8, 2013
PharmiWeb, 2 days ago
Investigators at University of Pennsylvania Discuss Findings in Breast Cancer
NewsRX, 2 days ago
Ariad Pharmaceuticals Inc. Presents at UBS Global Healthcare Conference, May-20-2013 08:30 AM
Seeking Alpha, 6 days ago
|
Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular dockingThis content is free, please choose one of the three options provided in the Log in section to gain access. Please choose one of the options provided in the log in section to gain access to this content: Vascular endothelial growth factor receptor-2 ... RSC, 2 weeks ago
Analysis of Serum Metabolites for the Discovery of Amino Acid Biomarkers and the Effect of Galangin on Cerebral Ischemia
RSC, 2 days ago
|